News about Safety

Freudenberg accomplishes ISO 14001 accreditation for its 11 overall destinations

Freudenberg accomplishes ISO 14001 accreditation for its 11 overall destinations

Freudenberg Medical has accomplished ISO 14001 confirmation for every one of the 11 locales in the United States, Costa Rica, Germany, Ireland, and China. Meaning, all Freudenberg Medical activities overall satisfy the most noteworthy guidelines for ecological administration.

Safety | 13/04/2022 | By Sudeep Soparkar

Generic Pradaxa Capsules from Alembic Pharma given tentative approval by the US FDA

Generic Pradaxa Capsules from Alembic Pharma given tentative approval by the US FDA

Alembic Pharmaceuticals Limited has gotten speculative endorsement from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for dabigatran etexilate cases, 75 mg, 110 mg, and 150 mg.

Safety | 08/04/2022 | By Sudeep Soparkar

COVID medicines medical devices: parliamentary panel for framing price control regime

COVID medicines medical devices: parliamentary panel for framing price control regime

A Parliamentary panel has recommended framing a new price control regime specific for medicines and medical devices for COVID-19 management and put them under price control with no annual increase in prices allowed till the pandemic is entirely over in the country

Safety | 22/03/2022 | By Darshana

A Synopsis Of Themis Medicare Viralex

A Synopsis Of Themis Medicare Viralex

Mumbai-based pharmaceutical company Themis Medicare?s anti-viral drug Viralex has received Drugs Controller General of India?s (DCGI) approval, the company informed the stock exchange on Monday

Safety | 21/03/2022 | By Darshana

Second R&D Center Of Boston Scientific Corporation Inaugurated In Pune

Second R&D Center Of Boston Scientific Corporation Inaugurated In Pune

The second Research and Development Center is launched by the Boston Scientific Corporation in Pune. The major goal of this move is to make capital out of India?s expertise in R&D and to provide manifold opportunities for engineers and front-runners in the country

Safety | 16/03/2022 | By Darshana

First reference lab in Kolkata launched by Lupin

First reference lab in Kolkata launched by Lupin

The new Reference Laboratory at Kolkata has capabilities to conduct a broad spectrum of routine and specialized tests in the fields of molecular diagnostics, cytogenetics, flow cytometry, histopathology, cytology, microbiology, serology, haematology, immunology and routine biochemistry

Safety | 11/03/2022 | By Darshana

National Pharmaceutical Pricing Authority fixes price for Intas Pharma's incremental immunoglobulin solution

National Pharmaceutical Pricing Authority fixes price for Intas Pharma's incremental immunoglobulin solution

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Intas Pharmaceuticals immunising agent immunoglobulin combination at 15 per cent higher than the existing human normal immunoglobulin solution for infusion 5%, since it is an incremental innovation having advantage without any increased side effect

Safety | 08/03/2022 | By Darshana

US FDA approval: CTI BioPharma's bone marrow cancer drug

US FDA approval: CTI BioPharma's bone marrow cancer drug

The drug, Vonjo (pacritinib), belongs to a class of anti-inflammatory treatments called JAK inhibitors, and will compete with Incyte Corp?s Jakafi and Bristol Myers? Inrebic, which were approved in 2011 and 2019 respectively for treating Myelofibrosis

Safety | 04/03/2022 | By Darshana

Drug Controller General issues a notice classifying 133 medical devices from general hospital and orthopaedic instruments

Drug Controller General issues a notice classifying 133 medical devices from general hospital and orthopaedic instruments

The decision comes as the latest in the drug regulator?s efforts to classify the medical devices sold in the country based on the perceived risk of the product type and its use in patients. The measure is to help the authority to bring in all the medical devices under the regulatory control, according to experts

Safety | 28/02/2022 | By Darshana

Stempeutics gets DCGI nod for phase-III clinical trial on its product for treating COVID patients

Stempeutics gets DCGI nod for phase-III clinical trial on its product for treating COVID patients

Stempeutics yesterday said it has received DCGI clearance to conduct phase-III clinical trial on its product for treating COVID-19 patients suffering from Acute Respiratory Distress Syndrome (ARDS). The company will be using its stem cell product, Stempeucel, for conducting the label extension phase-III clinical trial

Safety | 20/01/2022 | By Darshana

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology